Literature DB >> 26097995

Novel high-sensitivity troponin assay requires higher cut-off value to separate acute myocardial infarction from non-acute myocardial infarction in a high-risk population.

Anthony Wafik Aziz Wassef1,1, Brett Hiebert1,1, Mahwash F Saeed1,1, James W Tam1,1.   

Abstract

PURPOSE: The novel high-sensitivity troponin T assay (hs-cTnT) has been validated for diagnosing AMI in the emergency room. However its utility in high-risk in-patient populations is unknown.
METHODS: We retrospectively reviewed admissions to a general cardiology unit that had 2 hs-cTnT measurements in the first 12 h of presentation. We assessed 8 diagnostic algorithms that used hs-cTnT concentration and changes in concentration (including the 99th percentile cut-off of 14 ng/L) for their diagnostic utility in separating AMI patients from cardiac/nonACS and non-cardiac chest-pain patients. UA was excluded.
RESULTS: There were 233 patients (mean age 67 years, 153 were males (66%)) admitted over a 2 month period, with AMI diagnosed in 118 of these patients (51%). The recommended 99th percentile cut-off had modest accuracy (65%), good sensitivity (88%), and poor specificity (25%); a higher cut-off of 75 ng/L had a better diagnostic accuracy of 73%, p < 0.05. While some hs-cTnT algorithms were either highly sensitive or specific, none were both.
CONCLUSION: In high-risk cardiology in-patients, no hs-cTnT concentration cut-off or change more accurately diagnosed and excluded AMI, although higher cut-offs had better diagnostic utility.

Entities:  

Keywords:  acute coronary syndromes; biomarqueurs cardiaques; cardiac biomarkers; coronary artery disease; high sensitivity troponin; infarctus du myocarde; maladie coronarienne; myocardial infarction; syndromes coronariens aigus; troponine hypersensible

Mesh:

Substances:

Year:  2015        PMID: 26097995     DOI: 10.1139/cjpp-2014-0473

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  2 in total

1.  Relationship between high-sensitivity cardiac troponin T and the prognosis of elderly inpatients with non-acute coronary syndromes.

Authors:  Wei Wu; Dong-Xia Li; Qing Wang; Ying Xu; Yun-Jing Cui
Journal:  Clin Interv Aging       Date:  2018-06-06       Impact factor: 4.458

2.  Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients.

Authors:  Jie-Ruo Chen; Qing Wang; Wei Wu; Shao-Jing Zhang
Journal:  Clin Interv Aging       Date:  2018-12-31       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.